AVRAnteris Technologies Global Corp.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Revenue
- $2M
- 29% YoY
- Operating margin
- -4908.2%
- 69% YoY
- EBITDA
- −$92M
- 20% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- −$250M net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCFired407% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear—Over 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2024 | FY2025 | YoY |
|---|---|---|---|
| Revenue | $3M | $2M | 29% |
| Operating income | −$78M | −$94M | 20% |
| Net income | −$76M | −$94M | 23% |
| Operating cash flow | −$61M | −$78M | 27% |
| Capex | $2M | $2M | 14% |
| Stock-based comp | $7M | $8M | 19% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $12M · 5
- Open-market sells, 12 mo
- $0 · 0
- Net
- $12M
Pay vs performance
No pay-versus-performance disclosure yet.